ArticleThoracic cancer2021

Long-term response to afatinib in an elderly patient with uncommon epidermal growth factor receptor mutation-positive lung adenocarcinoma.

Naoki Shijubou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.